Zimmer Biomet Holdings Inc [ZBH] stock prices are up 0.54% to $99.92 at the moment. In order to assess the stock’s recent performance, you can check whether its short-term value is rising or falling.
From an analyst’s perspective:
Zimmer Biomet Holdings Inc [NYSE: ZBH] stock has seen the most recent analyst activity on September 18, 2025, when Rothschild & Co Redburn initiated its Buy rating and assigned the stock a price target of $130. Previously, Roth Capital upgraded its rating to Buy on July 15, 2025, and kept the price target unchanged to $135. On December 17, 2024, upgrade upgraded it’s rating to Overweight and revised its price target to $128 on the stock. Wolfe Research started tracking the stock assigning a Peer Perform rating. Piper Sandler downgraded its rating to a Neutral and reduced its price target to $115 on July 01, 2024. Goldman started tracking with a Neutral rating for this stock on May 30, 2024, and assigned it a price target of $129. In a note dated May 21, 2024, Argus upgraded a Buy rating on this stock but restated the target price of $150.
The stock price of Zimmer Biomet Holdings Inc [ZBH] has been fluctuating between $89.22 and $114.72 over the past year. Currently, Wall Street analysts expect the stock to reach $110.86 within the next 12 months. Zimmer Biomet Holdings Inc [NYSE: ZBH] shares were valued at $99.92 at the most recent close of the market. An investor can expect a potential return of 10.95% based on the average ZBH price forecast.
Analyzing the ZBH fundamentals
The Zimmer Biomet Holdings Inc [NYSE:ZBH] reported sales of 7.83B for trailing twelve months, representing a surge of 6.97%. Gross Profit Margin for this corporation currently stands at 0.71% with Operating Profit Margin at 0.16%, Pretax Profit Margin comes in at 0.12%, and Net Profit Margin reading is 0.11%. To continue investigating profitability, this company’s Return on Assets is posted at 0.04, Equity is 0.07 and Total Capital is 0.06. Upon thorough examination of the company’s fundamental financial framework, it becomes apparent that the debt-to-equity ratio stands at 0.6.
Before buying any particular stock, readers tend to pay close attention to the indicators that support and create resistance. The company’s stock is currently sitting at 99.25 points at the first support level, and at 98.58 for the second support level. However, for the 1st resistance point, the stock is sitting at 100.57, and for the 2nd resistance point, it is at 101.23.
Ratios To Look Out For
It’s worth pointing out that Zimmer Biomet Holdings Inc [NYSE:ZBH]’s Current Ratio is 1.87. In addition, the Quick Ratio stands at 0.96 and the Cash Ratio stands at 0.21. Considering the valuation of this stock, the price to sales ratio is 2.53, the price to book ratio is 1.58 and price to earnings (TTM) ratio is 24.33.
Transactions by insiders
Recent insider trading involved Yi Sang, Group President, Asia Pacific, that happened on Sep 11 ’25 when 1200.0 shares were sold. Officer, Yi Sang completed a deal on Sep 11 ’25 to buy 1200.0 shares. Meanwhile, SVP and CHRO Winkler Lori sold 1500.0 shares on Sep 08 ’25.
